| Sources | Names Used |
|---|---|
| CTRPv2 | 1S,3R-RSL-3 |
| PharmacoGx | 1S,3R-RSL-3 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIF9 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | GIT2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | UQCRC1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | TGFB1I1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | APC2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | PCDHA10 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | MTERF3 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | CKAP2 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | EZH1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | TPD52L1 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
